Lexicon Pharmaceuticals Aktie WKN: 936717 ISIN: US5288721047 Symbol: LXRX Typ: Aktie
eröffnet am 13.03.15 09:18:58 von
neuester Beitrag 13.03.24 08:55:25 von
neuester Beitrag 13.03.24 08:55:25 von
Beiträge: 151
ID: 1.209.260
ID: 1.209.260
Aufrufe heute: 1
Gesamt: 16.545
Gesamt: 16.545
Aktive User: 0
ISIN: US5288723027 · WKN: A14SSK · Symbol: LXRX
1,7600
USD
-5,88 %
-0,1100 USD
Letzter Kurs 01:21:39 Nasdaq
Neuigkeiten
03.04.24 · globenewswire  |
25.03.24 · globenewswire |
12.03.24 · globenewswire |
11.03.24 · globenewswire |
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 3.000,00 | +74.900,00 | |
| 0,9300 | +54,46 | |
| 5,9299 | +42,55 | |
| 3,0800 | +38,12 | |
| 2,4700 | +33,51 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 2,2600 | -19,29 | |
| 1,4300 | -24,34 | |
| 1,4700 | -27,76 | |
| 2,2000 | -31,25 | |
| 1,4300 | -49,56 |
Beitrag zu dieser Diskussion schreiben
Feedback
Vorgestern 29% up, gestern 20% down 
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasd…
New major risk - Share price stability
The company's share price has been highly volatile over the past 3 months.
It is more volatile than 90% of American stocks, typically moving 17% a week.
This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent.
Currently, the following risks have been identified for the company:
Major Risk
Share price has been highly volatile over the past 3 months (17% average weekly change).
Minor Risks
Currently unprofitable and not forecast to become profitable over next 3 years (US$107m net loss in 3 years).
Shareholders have been diluted in the past year (29% increase in shares outstanding).
Revenue is less than US$5m (US$1.2m revenue).
https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasd…
New major risk - Share price stability
The company's share price has been highly volatile over the past 3 months.
It is more volatile than 90% of American stocks, typically moving 17% a week.
This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent.
Currently, the following risks have been identified for the company:
Major Risk
Share price has been highly volatile over the past 3 months (17% average weekly change).
Minor Risks
Currently unprofitable and not forecast to become profitable over next 3 years (US$107m net loss in 3 years).
Shareholders have been diluted in the past year (29% increase in shares outstanding).
Revenue is less than US$5m (US$1.2m revenue).
Interesting article from the British Journal Cardiology
BSH 2023: collaboration, coordination and cooperation – 25in25
If you pop down to Table 4, you can see a trial fully funded for Sotagliflozin for HF and type 1 diabetes, assessing quality of life and safety
https://bjcardio.co.uk/2024/02/bsh-2023-collaboration-coordi…
BSH 2023: collaboration, coordination and cooperation – 25in25
If you pop down to Table 4, you can see a trial fully funded for Sotagliflozin for HF and type 1 diabetes, assessing quality of life and safety
https://bjcardio.co.uk/2024/02/bsh-2023-collaboration-coordi…
Antwort auf Beitrag Nr.: 75.265.977 von Weisbart am 12.02.24 19:51:09Up we go 
https://finance.yahoo.com/news/lexicon-pharmaceuticals-lxrx-…
Geldreserve aktuell $170 Mio
https://finance.yahoo.com/news/lexicon-pharmaceuticals-lxrx-…
Geldreserve aktuell $170 Mio
Ja macht Spaß die Aktie 😎🤠
Inpefa ist gelistet, wird von Kassen bezahlt
https://www.mass.gov/doc/pharmacy-facts-222-february-27-2024…
Jetzt wird Kohle gescheffelt
https://www.mass.gov/doc/pharmacy-facts-222-february-27-2024…
Jetzt wird Kohle gescheffelt
Trading Spotlight
Antwort auf Beitrag Nr.: 75.264.768 von Charly_2 am 12.02.24 17:02:18Aktie läuft $3.60
Widerstand $3.30 dann $4.50
Antwort auf Beitrag Nr.: 75.269.343 von Charly_2 am 13.02.24 11:31:38Link? 😁
Antwort auf Beitrag Nr.: 75.269.295 von Charly_2 am 13.02.24 11:25:56Von The Motley Fool
Liegt vielleicht daneben - nur kleiner Betrag als Spekulation investiert
Liegt vielleicht daneben - nur kleiner Betrag als Spekulation investiert
Durchsuchen
